Home
Adage Capital Management reported a 0.37% stake in Crescent Biopharma CBIO · 50,912 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 0.37%
- Last report
- No earlier report
- Shares held
- 50,912 sh
- Class
- Ordinary Shares, par value $0.001 per share
- Holder
- Adage Capital Management
- Event date
- 25/06/20
- Filed
- 25/06/20
0.37% stake · below 5%
Crescent Biopharma trades, last 26 weeks
What else happened in Crescent Biopharma around then
Filed or reported within 30 days of the trade day · 25/05/21~25/07/20Adage Capital Management's other 5% stake reports
- Adage Capital Management
5% stakeForefront Tech Holdings Acquisition
5% stakeForefront Tech Holdings Acquisition
FTHA
9% stake
900,000 sh
9% stake
Filed 08/12
- Adage Capital Management
5% stakeEquillium
5% stakeEquillium
EQ
7.25% stake
4,832,767 sh
7.25% stake
Filed 08/12
- Adage Capital Management
5% stakeEnergy Transition Special Opportunities
5% stakeEnergy Transition Special Opportunities
ETSS
9% stake
1,350,000 sh
9% stake
Filed 08/12
- Adage Capital Management
5% stakeCybin
5% stakeCybin
HELP
5.29% stake
3,289,250 sh
5.29% stake
Filed 08/12
- Adage Capital Management
5% stakeYorkville International Capital
5% stakeYorkville International Capital
YICC
7.83% stake
1,800,000 sh
7.83% stake
Filed 08/12
